Yestar Healthcare Holdings Co Ltd (HK:2393)
:2393
Top Page
Yestar Healthcare Holdings Co Ltd
(2393)
Select Model
Select Model
Rating:40Underperform
Price Target:
HK$0.11
▲(8.00% Upside)
Action:DowngradedDate:01/21/26
The score is driven primarily by weak financial performance (declining profitability, leverage/negative equity history, and poor cash generation). Technical indicators are mixed but lean weak with negative MACD and the price not reclaiming key longer-term averages. Valuation provides limited support due to a negative P/E and no stated dividend yield.
Positive Factors
Recurring equipment sales and service contracts
A mix of equipment sales and recurring service/maintenance contracts creates a durable revenue base. Service contracts provide predictable annuity-like cash flows, smoothing cyclicality of capital sales and supporting long-term customer relationships and aftermarket margins over multiple quarters.
Negative Factors
Historical negative equity and weak balance sheet
Persistent negative equity historically signals cumulative losses and high financial risk. A structurally weak balance sheet limits the company's ability to invest, raises refinancing and covenant risks, and constrains strategic options if profits and cash flow do not sustainably recover.
Read all positive and negative factors
Positive Factors
Negative Factors
Recurring equipment sales and service contracts
A mix of equipment sales and recurring service/maintenance contracts creates a durable revenue base. Service contracts provide predictable annuity-like cash flows, smoothing cyclicality of capital sales and supporting long-term customer relationships and aftermarket margins over multiple quarters.
Read all positive factors
Yestar Healthcare Holdings Co Ltd (2393) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$230.63M
Dividend YieldN/A
Average Volume (3M)2.34M
Price to Earnings (P/E)10.4
Beta (1Y)0.46
Revenue Growth6.10%
EPS Growth-115.12%
CountryHK
Employees627
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)-0.04
Shares Outstanding2,331,590,000
10 Day Avg. Volume1,184,000
30 Day Avg. Volume2,342,546
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.29
Price to Sales (P/S)0.06
P/FCF Ratio-5.14
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Yestar Healthcare Holdings Co Ltd Business Overview & Revenue Model
Company Description
Yestar Healthcare Holdings Company Limited, an investment holding company, engages in the manufacture, distribution, and sale of medical imaging products in Mainland China. It operates through two segments, Imaging Printing Products, and Medical P...
How the Company Makes Money
Yestar Healthcare Holdings generates revenue through multiple key streams. Primarily, the company earns income from the sale of its medical imaging equipment and diagnostic devices to hospitals and healthcare facilities. Additionally, Yestar provi...
Yestar Healthcare Holdings Co Ltd Financial Statement Overview
Summary
Income Statement
45
Neutral
Balance Sheet
35
Negative
Cash Flow
30
Negative
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.94B | 2.41B | 2.91B | 2.80B | 4.93B | 4.11B |
| Gross Profit | 315.30M | 399.20M | 512.78M | 397.55M | 848.70M | 806.88M |
| EBITDA | -78.16M | -51.93M | 376.81M | 19.13M | 315.89M | 305.49M |
| Net Income | -161.86M | 921.61M | -13.89M | -992.23M | 3.33M | -590.49M |
Balance Sheet | ||||||
| Total Assets | 1.36B | 1.43B | 3.43B | 3.37B | 4.56B | 4.66B |
| Cash, Cash Equivalents and Short-Term Investments | 249.36M | 151.78M | 251.56M | 418.15M | 751.77M | 625.20M |
| Total Debt | 281.42M | 316.90M | 1.63B | 1.90B | 1.79B | 1.84B |
| Total Liabilities | 839.91M | 921.84M | 3.82B | 3.71B | 3.73B | 3.80B |
| Stockholders Equity | 469.65M | 461.60M | -457.50M | -408.87M | 755.23M | 757.04M |
Cash Flow | ||||||
| Free Cash Flow | 239.65M | -26.45M | 294.22M | -115.58M | 665.55M | 591.92M |
| Operating Cash Flow | 272.74M | 12.72M | 387.67M | -91.73M | 715.22M | 670.73M |
| Investing Cash Flow | -31.65M | 380.42M | -89.82M | -18.72M | -47.67M | -37.21M |
| Financing Cash Flow | -124.65M | -502.63M | -234.37M | -180.86M | -654.20M | -604.74M |
Yestar Healthcare Holdings Co Ltd Technical Analysis
Negative
0.10
Price Trends
0.11
Negative
0.11
Negative
0.13
Negative
Market Momentum
>-0.01
Negative
41.35
Neutral
65.27
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2393, the sentiment is Negative. The current price of 0.1 is below the 20-day moving average (MA) of 0.10, below the 50-day MA of 0.11, and below the 200-day MA of 0.13, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 41.35 is Neutral, neither overbought nor oversold. The STOCH value of 65.27 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2393.
Yestar Healthcare Holdings Co Ltd Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$6.40B | 9.87 | 6.19% | 2.76% | 13.59% | 6.31% | |
71 Outperform | HK$606.52M | 5.13 | 16.21% | 4.94% | 17.93% | 36.82% | |
62 Neutral | HK$1.56B | 13.30 | 4.43% | 2.82% | -3.32% | -12.94% | |
52 Neutral | HK$410.07M | 12.16 | 4.12% | ― | -2.77% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
44 Neutral | HK$547.05M | -2.91 | -16.83% | ― | 11.43% | 4.88% | |
40 Underperform | HK$230.63M | 10.43 | -34.76% | ― | 6.10% | -115.12% |
* Healthcare Sector Average
HK:2393
Yestar Healthcare Holdings Co Ltd
0.10
0.03
41.43%
HK:1612
Vincent Medical Holdings Limited
0.92
0.54
142.11%
HK:1696
Sisram Medical Ltd.
3.34
-0.77
-18.73%
HK:1763
China Isotope & Radiation Corp.
20.00
9.51
90.66%
HK:2170
Suzhou Basecare Medical Corp. Ltd. Class H
2.00
-0.90
-31.03%
HK:6118
Austar Lifesciences Ltd.
0.80
0.02
2.56%
Yestar Healthcare Holdings Co Ltd Corporate Events
Yestar Healthcare Ventures into Advanced Materials Industry
Dec 15, 2025
Yestar Healthcare Holdings Co Ltd has announced its strategic move to invest in the advanced materials industry, recognizing the sector’s robust global growth. The company aims to become a pioneer in Southeast Asia by acquiring coating techn...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.